Oneness Biotech Co., Ltd.

NT$44.95As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4743Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 4.89%
Div yield —
ROE 0.62%
Biotechnology
Beta (5Y) 0.77
PE TTM 354.8
TSR TTM (30.63%)
Mkt cap NT$21.55B
ROIC (12.48%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$58
27.98%
(35.11%)
Hold 11|11|4|0|3
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.62
0.69
0.67
0.72
31.16%
42.21%
29.00%
23.94%
RevenueNT$B
1.244
1.296
1.342
1.310
13.99%
18.38%
20.21%
10.85%
Peers (US$651.0M)
Cap (US$)
PE
486.7M
—
Capital
TTM
5Y
10Y
Leveragex
0.879
0.997
0.757
EBIT/Intx
0.703
0.170
0.117
Own earn%
43.64
(79.46)
(81.98)
Sh yield%
17.21
41.22
42.54
Owners
Insiders/Inst%
8.17
42.16
Short interest%
5.68
SBC / revenue%
5.88
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
22–29
$1 testx
—
Incr. ROIC%
2